Annual Activities Report 2011 - INCT-Inofar - UFRJ
Annual Activities Report 2011 - INCT-Inofar - UFRJ
Annual Activities Report 2011 - INCT-Inofar - UFRJ
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Annual</strong> <strong>Report</strong> <strong>2011</strong> | <strong>INCT</strong>-INOFAR<br />
14<br />
Presentation<br />
Pharmaceutical<br />
Innovation<br />
With the help of its entire research network, <strong>INCT</strong>-INOFAR studies and develops several<br />
subprojects classified as radical innovation. It is also a part, in a more minor role, in<br />
incremental innovation subprojects, studying new routes for the total synthesis of generic<br />
pharmaceuticals.<br />
In the field of radical innovation, the Institute aims to discover/invent original substances,<br />
active in in vivo pharmacological models, widely validated, that are capable of originating<br />
new pharmaceutical candidates in several therapeutic classes.<br />
In the field of incremental innovation, <strong>INCT</strong>-INOFAR leads projects that focus on the<br />
search of new, efficient, and accessible synthetic routes, for generic drugs already available<br />
in the market – and that represent important tools in public health policies and in the<br />
pharmaceutical care of the population – as well as for those medications that are about to<br />
have their patents expire, and that represent new business opportunities from a marketing<br />
point of view.<br />
<strong>INCT</strong>-INOFAR Research Areas<br />
- Inflammation<br />
- Pulmonary Disease<br />
- Pain<br />
- Central Nervous System<br />
- Cardiovascular System<br />
- Chemotherapy: anticancer and antiparasitic<br />
- Generic Drugs
Change language